Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27700 | 223 | 46.3 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
441 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 26474 |
306 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 18497 |
27700 | 1 | JOINT SERV BIOMARKER EVALUAT ONCOL//KI67 SCORE//LOCDIR | 223 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | JOINT SERV BIOMARKER EVALUAT ONCOL | address | 273860 | 1% | 100% | 2 |
2 | KI67 SCORE | authKW | 273860 | 1% | 100% | 2 |
3 | LOCDIR | authKW | 273860 | 1% | 100% | 2 |
4 | MIR 1284 | authKW | 273860 | 1% | 100% | 2 |
5 | P53 BAX PATHWAY | authKW | 273860 | 1% | 100% | 2 |
6 | DNA NICK END LABELING | authKW | 182572 | 1% | 67% | 2 |
7 | ADENOMATOUS COMPONENT | authKW | 136930 | 0% | 100% | 1 |
8 | AGNOR NUMBER | authKW | 136930 | 0% | 100% | 1 |
9 | BAX MSI PHENOTYPE | authKW | 136930 | 0% | 100% | 1 |
10 | BCL 2 RELATED FAMILY OF PROTEINS | authKW | 136930 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2149 | 51% | 0% | 113 |
2 | Pathology | 1002 | 19% | 0% | 43 |
3 | Gastroenterology & Hepatology | 527 | 15% | 0% | 34 |
4 | Surgery | 140 | 15% | 0% | 34 |
5 | Cell Biology | 42 | 9% | 0% | 20 |
6 | Medical Laboratory Technology | 32 | 2% | 0% | 5 |
7 | Medicine, Research & Experimental | 28 | 5% | 0% | 12 |
8 | Microscopy | 12 | 1% | 0% | 2 |
9 | Anatomy & Morphology | 6 | 1% | 0% | 2 |
10 | Developmental Biology | 5 | 1% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOINT SERV BIOMARKER EVALUAT ONCOL | 273860 | 1% | 100% | 2 |
2 | BRAIN KOREA PROJECT MAT SCI 21 | 136930 | 0% | 100% | 1 |
3 | DIGEST SURG DIGEST METAB DIS | 136930 | 0% | 100% | 1 |
4 | EXPT MED PATHOL CYTOPATHOL 1 | 136930 | 0% | 100% | 1 |
5 | FEDERATIF RECH GEIST GENOM | 136930 | 0% | 100% | 1 |
6 | FEDERATIF RECH GENOM ENVIRONM IMMUN SANTE | 136930 | 0% | 100% | 1 |
7 | FUNDAC HOSP ALCORON | 136930 | 0% | 100% | 1 |
8 | GEN EMERGENCY SURG CLIN 3 | 136930 | 0% | 100% | 1 |
9 | LIMOGES TEACHING HOSP | 136930 | 0% | 100% | 1 |
10 | MED IMMUNOCYTOCHEM MOLEC PATHOL UNIT | 136930 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER BIOMARKERS | 3560 | 2% | 1% | 4 |
2 | VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 2047 | 1% | 1% | 2 |
3 | DIAGNOSTIC ONCOLOGY | 1439 | 0% | 1% | 1 |
4 | BRITISH JOURNAL OF CANCER | 1089 | 5% | 0% | 12 |
5 | JOURNAL OF PATHOLOGY | 875 | 3% | 0% | 6 |
6 | ANTICANCER RESEARCH | 855 | 5% | 0% | 11 |
7 | ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY | 825 | 1% | 0% | 3 |
8 | PATHOLOGY INTERNATIONAL | 771 | 2% | 0% | 4 |
9 | INTERNATIONAL JOURNAL OF COLORECTAL DISEASE | 717 | 2% | 0% | 4 |
10 | ACTA MICROSCOPICA | 607 | 0% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | KI67 SCORE | 273860 | 1% | 100% | 2 | Search KI67+SCORE | Search KI67+SCORE |
2 | LOCDIR | 273860 | 1% | 100% | 2 | Search LOCDIR | Search LOCDIR |
3 | MIR 1284 | 273860 | 1% | 100% | 2 | Search MIR+1284 | Search MIR+1284 |
4 | P53 BAX PATHWAY | 273860 | 1% | 100% | 2 | Search P53+BAX+PATHWAY | Search P53+BAX+PATHWAY |
5 | DNA NICK END LABELING | 182572 | 1% | 67% | 2 | Search DNA+NICK+END+LABELING | Search DNA+NICK+END+LABELING |
6 | ADENOMATOUS COMPONENT | 136930 | 0% | 100% | 1 | Search ADENOMATOUS+COMPONENT | Search ADENOMATOUS+COMPONENT |
7 | AGNOR NUMBER | 136930 | 0% | 100% | 1 | Search AGNOR+NUMBER | Search AGNOR+NUMBER |
8 | BAX MSI PHENOTYPE | 136930 | 0% | 100% | 1 | Search BAX+MSI+PHENOTYPE | Search BAX+MSI+PHENOTYPE |
9 | BCL 2 RELATED FAMILY OF PROTEINS | 136930 | 0% | 100% | 1 | Search BCL+2+RELATED+FAMILY+OF+PROTEINS | Search BCL+2+RELATED+FAMILY+OF+PROTEINS |
10 | BCL 23 | 136930 | 0% | 100% | 1 | Search BCL+23 | Search BCL+23 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | POINCLOUX, L , DURANDO, X , SEITZ, JF , THIVAT, E , BARDOU, VJ , GIOVANNINI, MH , PARRIAUX, D , BARRIERE, N , GIOVANNINI, M , DELPERO, JR , ET AL (2009) LOSS OF BCL-2 EXPRESSION IN COLON CANCER: A PROGNOSTIC FACTOR FOR RECURRENCE IN STAGE II COLON CANCER.SURGICAL ONCOLOGY-OXFORD. VOL. 18. ISSUE 4. P. 357-365 | 19 | 76% | 28 |
2 | KOORNSTRA, JJ , DE JONG, S , HOLLEMA, H , DE VRIES, EGE , KLEIBEUKER, JH , (2003) CHANGES IN APOPTOSIS DURING THE DEVELOPMENT OF COLORECTAL CANCER: A SYSTEMATIC REVIEW OF THE LITERATURE.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 45. ISSUE 1. P. 37-53 | 45 | 26% | 50 |
3 | GRIZZLE, WE , MANNE, U , WEISS, HL , JHALA, N , TALLEY, L , (2002) MOLECULAR STAGING OF COLORECTAL CANCER IN AFRICAN-AMERICAN AND CAUCASIAN PATIENTS USING PHENOTYPIC EXPRESSION OF P53, BCL-2, MUC-1 AND P27(KIP-1).INTERNATIONAL JOURNAL OF CANCER. VOL. 97. ISSUE 4. P. 403-409 | 20 | 51% | 22 |
4 | PETRISOR, O , GIUSCA, SE , SAJIN, M , DOBRESCU, G , CARUNTU, ID , (2008) KI-67, P53 AND BCL-2 ANALYSIS IN COLONIC VERSUS RECTAL ADENOCARCINOMA.ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY. VOL. 49. ISSUE 2. P. 163-171 | 20 | 43% | 4 |
5 | KOURAKLIS, G , KAKISIS, J , THEOHARIS, S , TZONOU, A , GLINAVOU, A , RAFTOPOULOS, J , KARATZAS, G , (2003) PROGNOSTIC SIGNIFICANCE AND CORRELATION WITH SURVIVAL OF BCL-2 AND TGF-BETA RII IN COLON CANCER.DIGESTIVE DISEASES AND SCIENCES. VOL. 48. ISSUE 12. P. 2284-2289 | 15 | 50% | 12 |
6 | MANNE, U , WEISS, HL , GRIZZLE, WE , (2000) BCL-2 EXPRESSION IS ASSOCIATED WITH IMPROVED PROGNOSIS IN PATIENTS WITH DISTAL COLORECTAL ADENOCARCINOMAS.INTERNATIONAL JOURNAL OF CANCER. VOL. 89. ISSUE 5. P. 423 -430 | 18 | 42% | 24 |
7 | REIMERS, MS , ZEESTRATEN, ECM , VAN ALPHEN, TC , DEKKER, JWT , PUTTER, H , SAADATMAND, S , LIEFERS, GJ , VAN DE VELDE, CJH , KUPPEN, PJK , (2014) COMBINED ANALYSIS OF BIOMARKERS OF PROLIFERATION AND APOPTOSIS IN COLON CANCER: AN IMMUNOHISTOCHEMISTRY-BASED STUDY USING TISSUE MICROARRAY.INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. VOL. 29. ISSUE 9. P. 1043 -1052 | 12 | 41% | 5 |
8 | MELINCOVICI, CS , MIHU, CM , MARGINEAN, M , BOSCA, AB , CONEAC, A , MOLDOVAN, I , CRISAN, M , (2016) THE PROGNOSTIC SIGNIFICANCE OF P53, BAX, BCL-2 AND CYCLIN E PROTEIN OVEREXPRESSION IN COLON CANCER - AN IMMUNOHISTOCHEMICAL STUDY USING THE TISSUE MICROARRAY TECHNIQUE.ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY. VOL. 57. ISSUE 1. P. 81 -89 | 13 | 35% | 1 |
9 | SUN, XF , BARTIK, Z , ZHANG, H , (2003) BCL-2 EXPRESSION IS A PROGNOSTIC FACTOR IN THE SUBGROUPS OF PATIENTS WITH COLORECTAL CANCER.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 23. ISSUE 5. P. 1439-1443 | 14 | 45% | 2 |
10 | DE OCA, J , AZUARA, D , SANCHEZ-SANTOS, R , NAVARRO, M , CAPELLA, G , MORENO, V , SOLA, A , HOTTER, G , BIONDO, S , OSORIO, A , ET AL (2008) CASPASE-3 ACTIVITY, RESPONSE TO CHEMOTHERAPY AND CLINICAL OUTCOME IN PATIENTS WITH COLON CANCER.INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. VOL. 23. ISSUE 1. P. 21-27 | 10 | 53% | 12 |
Classes with closest relation at Level 1 |